SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bhagiradha Chemicals & Industries informs about outcome of board meeting

06 Apr 2022 Evaluate
Bhagiradha Chemicals & Industries has informed that in relation to the Issue, the Board, at its meeting held on April 5, 2022, has approved the following: Issue Size and Price: Issue of up to 20,95,924 equity shares of face value Rs 10 each (Issue Shares) of our Company for cash at a price of Rs 400 per Equity Share (including a share premium of Rs 390 per Equity Share) (Issue Price), aggregating up to Rs 8,383.70 lakh by the Company. The issue comprises: an issue of up to 19,55,224 Equity Share to the Eligible Equity Shareholders of the Company on rights basis (Rights Equity Shares) aggregating up to 7,820.90 lakh in the ratio of 4 (four) Rights Equity Shares for every 17(seventeen) fully paid-up Equity Share held by the Eligible Equity Shareholders on the record date, that is on April 9, 2022; and a reservation of up to 1,40,700 Equity Share for the Eligible Employees of the Company (Employee Reservation Shares) aggregating up to Rs 562 80 lakh (Employee Reservation Portion); Rights Entitlement Ratio: 4 (four) Rights Equity Shares for every 17 (seventeen) fully paid-up Equity Shares held by the Eligible Equity Shareholders of the Company; Fixed record date for the purpose of determining the shareholders who will be eligible to apply for the Issue as Saturday, April 09, 2022 (Record Date);

The above information is a part of company’s filings submitted to BSE.

Bhagiradha Chem Share Price

220.20 6.95 (3.26%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×